Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02367170 · ClinicalTrials.gov registry record · Phase 1

Project 4A: Inspiratory Muscle Training and Diaphragm Strength

A Phase 1 study, sponsored by University of Florida.

Terminated
Registry status
Phase 1
Development phase
1
Enrollment target

NCT02367170 is a Phase 1 study that was terminated before completion, run by University of Florida. The registered enrollment target is 1 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02367170, a Phase 1 study, was terminated before completion, sponsored by University of Florida.

TERMINATED
Registry status
Phase 1
Development phase
1 participants
Enrollment target

Study Summary

Investigators will assess the effect of exercise on markers of inflammation and protein catabolism. This research study will further our understanding of how treating Chronic Critical illness (CCI) - related respiratory muscle weakness with strength training can not only improve muscle function, but also potentially blunt the inflammation and catabolism of Peristent Inflammation/Immunosuppression and Catabolism (PICS).

Interventions

  • DRUG Midazolam
  • DEVICE Inspiratory Muscle Strength Training (IMST)
  • PROCEDURE Bilateral phrenic nerve stimulation and measurement of transdiaphragmatic pressure
  • PROCEDURE Volitional Measurement of Maximal Inspiratory Pressure (MIP)
  • DEVICE SHAM Inspiratory Muscle Strength Training (IMST)

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2015-03
Est. Completion 2015-07
Phase Phase 1

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT02367170

The ClinicalTrials.gov registry entry for NCT02367170 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Midazolam is the first listed.

NCT02367170 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02367170 about?

NCT02367170 is a clinical study titled "Project 4A: Inspiratory Muscle Training and Diaphragm Strength". Investigators will assess the effect of exercise on markers of inflammation and protein catabolism. This research study will further our understanding of how treating Chronic Critical illness (CCI) - related respiratory muscle weakness with strength training can not only improve muscle function, but...

What is the current status of trial NCT02367170?

This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2015-03. Estimated completion is 2015-07.

What interventions are being tested in trial NCT02367170?

The interventions under investigation include: Midazolam (DRUG), Inspiratory Muscle Strength Training (IMST) (DEVICE), Bilateral phrenic nerve stimulation and measurement of transdiaphragmatic pressure (PROCEDURE), Volitional Measurement of Maximal Inspiratory Pressure (MIP) (PROCEDURE), SHAM Inspiratory Muscle Strength Training (IMST) (DEVICE).

Who is sponsoring clinical trial NCT02367170?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.